Giovanni Cammarota (G Cammarota)

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 26

Top Topics

Irritable Bowel Syndrome

Systematic Review

Metastatic Renal Cell Carcinoma

Clostridium Difficile

Top Venues

Alimentary pharmacology & therapeutics

Nature reviews. Gastroenterology & hepatology

Mediators of inflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut (2024)
Giovanni Cammarota, Gianluca G Ianiro
A greener gastroenterology: challenges and opportunities for an eco-sustainable approach to digestive diseases. Nature reviews. Gastroenterology & hepatology (2024)
Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut 73 (9) (2024)
Maria Rosa Ingrosso, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro
Letter: The multifaceted role of Escherichia coli in influencing disorders of industrial populations. Alimentary pharmacology & therapeutics 59 (5) (2024)
Serena Porcari, Maria Rosa Ingrosso, Marcello Maida, Leonardo Henry Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford, Gianluca G Ianiro
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut 73 (9) (2024)
Maria Rosa Ingrosso, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro
Letter: The multifaceted role of Escherichia coli in influencing disorders of industrial populations. Alimentary pharmacology & therapeutics 59 (5) (2024)
Maria Rosa Ingrosso, Antonio Gasbarrini, Giovanni Cammarota, Gianluca Ianiro
Letter: The multifaceted role of Escherichia coli in influencing disorders of industrial populations. Alimentary pharmacology & therapeutics 59 (5) (2024)
Loris Riccardo Lopetuso, Sara Deleu, Lihi Godny, Valentina Petito, Pierluigi Puca, Federica Facciotti, Harry Sokol, Gianluca G Ianiro, Luca Masucci, Maria Abreu, Iris Dotan, Samuel Paul Costello, Ailsa Hart, Tariq H Iqbal, Sudarshan Paramsothy, Maurizio Sanguinetti, Silvio Danese, Herbert Tilg, Fabio Cominelli, Theresa T Pizarro, Alessandro Armuzzi, Giovanni Cammarota, Antonio Gasbarrini, Severine Vermeire, Franco Scaldaferri
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut (2023)
Massimo Montalto, Antonella Gallo, Maria Chiara Agnitelli, Simona Pellegrino, Alice Lipari, Erika Pero, Marcello Covino, Francesco Landi, Antonio Gasbarrini, Giovanni Cammarota, Gianluca G Ianiro
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients. Journal of the American Geriatrics Society (2023)
Gianluca Quaranta, Gianluca G Ianiro, Flavio De Maio, Alessandra Guarnaccia, Giovanni Fancello, Chiara Agrillo, Federica Iannarelli, Stefano Bibbo, Amedeo Amedei, Sanguinetti Maurizio, Giovanni Cammarota, Luca Masucci
"Bacterial Consortium": A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection. BioMed research international 2022 (2022)
Qin Liu, Giovanni Cammarota, Gianluca G Ianiro
Evaluating microbial determinants of donor efficacy to translate faecal microbiota transplantation from research to clinical practice. Gut (2022)
Gianluca G Ianiro, Michal Punčochář, Nicolai Karcher, Serena Porcari, Federica Armanini, Francesco Asnicar, Francesco Beghini, Aitor Blanco-Míguez, Fabio Cumbo, Paolo Manghi, Federica Pinto, Luca Masucci, Gianluca Quaranta, Silvia De Giorgi, Giusi Desirè Sciumè, Stefano Bibbò, Federica Del Chierico, Lorenza Putignani, Sanguinetti Maurizio, Antonio Gasbarrini, Mireia Valles-Colomer, Giovanni Cammarota, Nicola Segata
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nature medicine 28 (9) (2022)
Gianluca G Ianiro, Benjamin Harvey Mullish, Colleen R Kelly, Zain Kassam, Ed J Kuijper, William K K Wu, Tariq H Iqbal, Jessica R Allegretti, Stefano Bibbò, Harry Sokol, Faming Zhang, Monika Fischer, Samuel Paul Costello, Josbert J Keller, Luca Masucci, Joffrey van Prehn, Gianluca Quaranta, Mohammed Nabil Nabil Quraishi, Jonathan P Segal, Dina Kao, Reetta Satokari, Maurizio Sanguinetti, Herbert Tilg, Antonio Gasbarrini, Giovanni Cammarota
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic. Gut 69 (9) (2020)
Gianluca G Ianiro, Serena Porcari, Alexander Charles Ford, Antonio Gasbarrini, Giovanni Cammarota
Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Alimentary pharmacology & therapeutics 52 (5) (2020)
Gianluca G Ianiro, Ernesto Rossi, Andrew Maltez Thomas, Giovanni Schinzari, Luca Masucci, Gianluca Quaranta, Carlo Romano Settanni, Loris Riccardo Lopetuso, Federica Armanini, Aitor Blanco-Miguez, Francesco Asnicar, Clarissa Consolandi, Roberto Iacovelli, Sanguinetti Maurizio, Giampaolo Tortora, Antonio Gasbarrini, Nicola Segata, Giovanni Cammarota
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma. Nature communications 11 (1) (2020)
Giovanni Cammarota, Gianluca G Ianiro, Anna Ahern, Carmine Carbone, Andriy Temko, Marcus Joakim Claesson, Antonio Gasbarrini, Giampaolo Tortora
Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nature reviews. Gastroenterology & hepatology 17 (10) (2020)
Gianluca G Ianiro, Francesca Romana Ponziani, Antonio Gasbarrini, Giovanni Cammarota
Letter: improvement of clinical outcomes by metformin in metabolic liver disease-a microbiota-dependent mechanism? Alimentary pharmacology & therapeutics 50 (4) (2020)
Cicilia Marcella, Bota Cui, Colleen R Kelly, Gianluca G Ianiro, Giovanni Cammarota, Faming Zhang
Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020. Alimentary pharmacology & therapeutics 53 (1) (2020)
Gianluca G Ianiro, Antonio Gasbarrini, Giovanni Cammarota
Autologous faecal microbiota transplantation for type 1 diabetes: a potential mindshift in therapeutic microbiome manipulation? Gut 70 (1) (2020)
Gianluca G Ianiro, Leonardo Henry Umberto Eusebi, Christopher J Black, Antonio Gasbarrini, Giovanni Cammarota, Alexander Charles Ford
Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Alimentary pharmacology & therapeutics 50 (3) (2019)
Giovanni Cammarota, Gianluca Ianiro
FMT for ulcerative colitis: closer to the turning point. Nature reviews. Gastroenterology & hepatology 16 (5) (2019)
Carmine Carbone, Geny Piro, Vincenzo Di Noia, Ettore D'Argento, Emanuele Vita, Miriam Grazia Ferrara, Sara Pilotto, Michele Milella, Giovanni Cammarota, Antonio Gasbarrini, Giampaolo Tortora, Emilio Bria
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer. Mediators of inflammation 2019 (2019)
Giovanni Cammarota, Gianluca Ianiro, Colleen R Kelly, Benjamin Harvey Mullish, Jessica R Allegretti, Zain Kassam, Lorenza Putignani, Monika Fischer, Josbert J Keller, Samuel Paul Costello, Harry Sokol, Patrizia Kump, Reetta Satokari, Stacy A Kahn, Dina Kao, Perttu Arkkila, Ed J Kuijper, Maria J Gt Vehreschild, Cristina Pintus, Loris Lopetuso, Luca Masucci, Franco Scaldaferri, E M Terveer, Max Nieuwdorp, Antonio López-Sanromán, Juozas Kupcinskas, Ailsa Hart, Herbert Tilg, Antonio Gasbarrini
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut 68 (12) (2019)
Stefano Bibbo, Gianluca Ianiro, Giovanni Mario Pes, Claudia Simonelli, Estelle E Newton, Giovanni Cammarota
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. Mediators of inflammation 2018 (2018)
Gianluca G Ianiro, L Masucci, G Quaranta, C Simonelli, Loris Riccardo Lopetuso, M Sanguinetti, A Gasbarrini, Giovanni Cammarota
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions. Alimentary pharmacology & therapeutics 48 (2) (2018)
Stefano Bibbo, Giovanni Mario Pes, Giovanni Cammarota
Response to: Comment on "Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease". Mediators of inflammation 2018 (2018)
Stefano Bibbò, Loris Riccardo Lopetuso, Gianluca Ianiro, Teresa Di Rienzo, Antonio Gasbarrini, Giovanni Cammarota
Role of microbiota and innate immunity in recurrent Clostridium difficile infection. Journal of immunology research 2014 (2014)